$AMRN unwanted waiting

AMRN

My own view!

·     The first quarter of 2018 was the worst price performance since 2013.

o  with a maximum of 4.60 and a low of 2.91.

·     The second quarter continued its loss, although it ended positively.

o  With a maximum of 3.52 and low of 2.66.

·     The third quarter aggravated the losses, and only a positive announcement could reverse the loss so far.

o  With a maximum of 3.32 and low of 2.35.

·     With an average of 3.81 up and 2.64 down, the price has had a real average yield of 30.71%.

·     These averages indicate to me that the price could be between 6.45 maximum and 1.17 minimum.

o  with a self-correction in 3.81.

·     Based on the current price, this may in case not favorable in the next report lower 30.70%, in the case of an excellent report go to up to 169.29%.

Recommendation,

·     For those traders whose cost is below 2.06 stay and wait, this level is the only healthy level to wait for this great announcement.

·     For those who are between 2.06 and 2.94 reduce their position by up to 75% and expect the announcement to be very low.

·     In the event that the report is good, the price will jump in the first hour to 3.81, and adding the previously reduced 75% after this level will give them a safe chance up to 6.45.

·     In the event that the report is negative they would only be losing an average of 0.45 cents, I would do that if I were at this cost level.

·     We are not in a position where we are assuring a positive result that has more than 15% chance, these studies enter unknown areas, there are no medical studies that guarantee that this area is possible a change greater than 50% in their results.

·     for those whose cost level is above 2.94 they will lose 60.21% of their investment funds in the event of a negative result.

·     Here we have two possibilities, although someone says there may be a possibility, we have a negative and a positive result, there are no average terms, I have an 85% chance that the news will not satisfy the almost elderly investors waiting for something here that eliminates many years of errors.

·     Over the next two weeks these indicators will show further deterioration, daily, monthly and quarterly averages will fade, and we have many opportunities in the market to trade against such a vital announcement for this company that has made dozens of mistakes.